0001567619-22-004752.txt : 20220216
0001567619-22-004752.hdr.sgml : 20220216
20220216175535
ACCESSION NUMBER: 0001567619-22-004752
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220215
FILED AS OF DATE: 20220216
DATE AS OF CHANGE: 20220216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hartman Thomas E
CENTRAL INDEX KEY: 0001466989
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 22644918
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2022-02-15
0
0000722723
HANGER, INC.
HNGR
0001466989
Hartman Thomas E
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
0
1
0
0
SVP and General Counsel
Common Stock
2022-02-15
4
A
0
6880
0
A
138898
D
Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2021 and ending on December 31, 2021. These performance shares vest in equal tranches over a four year period, commencing on the first anniversary of the grant date.
Consists of (i) unvested restricted shares totaling 6,880 shares of stock from an initial grant of 6,880 shares of restricted stock that begins to vest on March 8, 2022; (ii) unvested restricted shares totaling 8,665 shares of stock from an initial grant of 8,665 shares of restricted stock that begins to vest on March 8, 2022 (iii) unvested restricted shares totaling 6,111 shares of stock from an initial grant of 6,778 shares of restricted stock that begins to vest on March 9, 2021 (iv) unvested restricted shares totaling 7,188 shares of stock from an initial grant of 7,973 shares of restricted stock that begins to vest on March 9, 2021; [continued in next footnote]
(v) unvested restricted shares and fully vested shares totaling 6,190 shares of stock from an initial grant of 7,708 shares of restricted stock made on March 8, 2019;(vi) unvested restricted shares and fully vested shares totaling 7,336 shares of stock from an initial grant of 9,134 shares of restricted stock made on March 8, 2019; (vii) unvested restricted shares and fully vested shares totaling 6,293 shares of stock from an initial grant of 8,868 shares of restricted stock made on March 9, 2018; (viii) unvested restricted shares and fully vested shares totaling 6,813 shares of stock from an initial grant of 10,500 shares of restricted stock, the remainder of which vested on March 8, 2021; [continued in next footnote]
(ix) unvested restricted shares and fully vested shares totaling 7,912 shares of stock from an initial grant of 11,147 shares of restricted stock made on March 9, 2018; (x) fully vested shares totaling 4,363 shares of stock from an initial grant of 6,359 shares of restricted stock made on March 6, 2015; (xi) unvested restricted shares and fully vested shares totaling 6,489 shares of stock from an initial grant of 10,000 shares of restricted stock made on March 8, 2017; (xii) fully vested shares totaling 3,394 shares of stock from an initial grant of 5,000 shares of restricted stock made on October 11, 2016; (xiii) unvested restricted shares and fully vested shares totaling 4,980 shares of stock from an initial grant of 10,000 shares of restricted stock made on April 29, 2016; [continued in next footnote]
(xiv) fully vested shares totaling 3,513 shares of stock from an initial grant of 4,958 shares of restricted stock made on November 10, 2015; (xv) fully vested shares totaling 2,432 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015; (xvi) fully vested shares totaling 764 shares of stock from an initial grant of 1,731 shares of restricted stock made on March 7, 2014; (xvii) fully vested shares totaling 878 shares of stock from an initial grant of 3,246 shares of restricted stock and performance made on March 11, 2013; and [continued in next footnote]
(xix) fully vested shares totaling 1,200 shares from an initial grant of 4,800 shares of restricted stock made on March 7, 2012.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Hartman
2022-02-16